No Picture
News

REGEN BIOPHARMA, INC.: MESSAGE TO THE SHAREHOLDERS FROM THE CHAIRMAN AND CHIEF EXECUTIVE OFFICER

SAN DIEGO: SAN DIEGO, Dec. 30, 2021 /PRNewswire/ — Regen BioPharma, Inc. (PINK: RGBP) and (PINK: RGBPP): First of all I would like to wish all our shareholders a happy holiday season. It has been a long year with many challenges and many successes. When I returned to Regen on… Click here to view original post… […]

No Picture
News

Palisade Bio to Present at the H.C. Wainwright BIOCONNECT Virtual Conference and Biotech Showcase

CARLSBAD, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, announces that they will present at the H.C. Wainwright BIOCONNECT Virtual Conference taking place January 10-13, 2022, and at Biotech Showcase taking place… Click here to view original post… […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Uncategorized

Scientist/ Senior Scientist, Next Generation Sequencing – AlivaMab Discovery Services – San Diego, CA

Scientist to develop and implement NGS workflows for custom therapeutic antibody discovery projects. This position works closely with other laboratory members…From AlivaMab Discovery Services – Thu, 30 Dec 2021 00:32:40 GMT – View all San […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Uncategorized

Associate Scientist, Purification Sciences Discovery Chemistry – Johnson & Johnson Family of Companies – La Jolla, CA

Janssen Discovery Chemistry group is committed to the delivery of high-quality drug candidates working with all six Janssen Therapeutic Areas (TAs).From Johnson & Johnson Family of Companies – Wed, 29 Dec 2021 08:07:20 GMT – […]

No Picture
News

Ionis and AstraZeneca close deal to develop and commercialize eplontersen

CARLSBAD, Calif.: CARLSBAD, Calif., Dec. 29, 2021 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in RNA-targeted therapies, today announced the closing of the collaboration agreement with AstraZeneca to develop and commercialize eplontersen, Ionis’ investigational antisense medicine for the treatment of transthyretin amyloidosis (ATTR), following expiration of the waiting… Click here to view original post… […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Sorrento Therapeutics Mexico Executes Second Contract for Sale of 10 Million COVISTIX Tests for Mexico Market

SAN DIEGO and MEXICO CITY, Dec. 27, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today its subsidiary, Sorrento Therapeutics Mexico (“Sorrento Mexico”), has executed a second contract with a large distributor for the sale and distribution of up to 10 million COVISTIX™ tests for the… Click here to view original post… […]

No Picture
News

Sorrento Announces COVISTIX COVID-19 Virus Rapid Antigen Detection Test Detects the Omicron Variant

SAN DIEGO, Dec. 27, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today that initial testing of COVISTIX on recombinant N proteins demonstrated its ability to detect the Omicron variant, in addition to detecting the original SARS-CoV-2 virus and its other major VoCs such as the… Click here to view original post… […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Uncategorized

Bioinformatics Postdoc – Systems Immunology of Infectious Diseases – La Jolla Institute for Immunology – San Diego, CA

We are looking to fill a postdoctoral position with experience in the analysis of sequencing data and immunology.From La Jolla Institute for Immunology – Mon, 27 Dec 2021 22:07:52 GMT – View all San Diego, […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Uncategorized

Associate Director / Principal Scientist, Flow Cytometry Cell Therapy Analytics – Fate Therapeutics – San Diego, CA

Cytometry expertise to join the Analytical Development team. Responsible for leading development and qualification of flow cytometry analytical methods to…From Fate Therapeutics – Fri, 24 Dec 2021 02:15:13 GMT – View all San Diego, CA […]

No Picture
Uncategorized

Quality Assurance Associate III / II, Quality CMO Management – Fate Therapeutics – San Diego, CA

And support for Fate’s external cGMP manufacturing operations. The successful candidate will work. Closely with Contract Manufacturing Organizations (CMO) and…From Fate Therapeutics – Fri, 24 Dec 2021 02:15:02 GMT – View all San Diego, CA […]

No Picture
Uncategorized

Research Assistant II (Mass Spectrometry) – Dr. Christian Metallo – The Salk Institute for Biological Studies – La Jolla, CA

The successful candidate will support maintenance and operation of gas chromatography-mass spectrometry (GC-MS) systems for metabolomics analysis of cell,…From Indeed – Fri, 24 Dec 2021 00:26:39 GMT – View all La Jolla, CA jobsClick here […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Illumina To Webcast Upcoming Investor Conference

SAN DIEGO: SAN DIEGO, Dec. 23, 2021 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference: J.P. Morgan Annual Healthcare Conference on January 10, 2022 Presentation at 12:45pm Pacific Time (3:45pm Eastern Time) immediately followed by a Q&A Session to… Click here to view original post… […]

No Picture
News

‘Pop-up’ Electronic Sensors Could Detect When Individual Heart Cells Misbehave

UC San Diego engineers developed a powerful new tool that directly measures the movement and speed of electrical signals inside heart cells, using tiny “pop-up” sensors that poke into cells without damaging them. It could be used to gain more detailed insights into heart disorders and… Click here to view original post… […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Tryp Therapeutics Announces Advancement of Phase 2a Clinical Trial in Binge Eating Disorder

SAN DIEGO: SAN DIEGO, Dec. 23, 2021 /PRNewswire/ — Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, announced today the receipt of correspondence from the U.S. Food and Drug Administration (FDA) affirming the Company’s… Click here to view original post… […]

No Picture
News

Joan Shen ends the year by saying goodbye to I-Mab; CRISPR Therapeutics puts coal in R&D chief’s stocking

Deck the halls with more appointments in the last Peer Review for 2021. Thanks for reading every week! Joan Shen ? When the calendar flips to 2022, Joan Shen is out at I-Mab “to pursue other interests,” leaving founder and chairman Jingwu Zang … […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Homelessness Increases Serious Illness, Emergency Room Visits During Heat Waves

UC San Diego researchers in the Herbert Wertheim School of Public Health, Scripps Institution of Oceanography and Department of Emergency Medicine, discuss the health impacts of heat waves on people experiencing homelessness, emergency department visits and which characteristics make them at-risk. Click here to view original post… […]

No Picture
News

Tryp Therapeutics Announces Fiscal Year 2021 Financial Results and Reports on Corporate Highlights

SAN DIEGO: SAN DIEGO, Dec. 22, 2021 /PRNewswire/ — Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, announced today the filing of its audited financial statements for the fiscal year ending August 31, 2021… Click here to view original post… […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

‘Disappointing’ ViaCyte data raise questions about future of company’s attempted diabetes cure

Over the last 20 years, ViaCyte — under one name or another — has pursued one of the most audacious goals in biotech: a cure for type 1 diabetes. The company’s plan was to take lab-grown stem cells and turn them into the insulin-producing cells that are destroyed in T1D… Click here to view original post… […]

No Picture
News

SkylineDx and VIB enter a strategic partnership in molecular diagnostics

ROTTERDAM, Netherlands and SAN DIEGO and GHENT, Belgium: ROTTERDAM, Netherlands and SAN DIEGO and GHENT, Belgium, Dec. 22, 2021 /PRNewswire/ — Today, SkylineDx announced a 3-year strategic partnership with life sciences institute VIB for the evaluation and initiation of collaborative projects focused on molecular diagnostics. Under the agreement, SkylineDx and… Click here to view original post… […]

No Picture
News

CDC Publishes AXIM® Biotechnologies-Sponsored Study on COVID-19 Neutralizing Antibodies

SAN DIEGO, Dec. 21, 2021 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting COVID-19 diagnostics, oncological research, and dry eye disease, announced today that the Centers for Disease Control and Prevention (CDC) highlighted a study that the Company… Click here to view original post… […]